Cargando…
Angiotensin-converting enzyme 2 improves hepatic insulin resistance by regulating GABAergic signaling in the liver
The angiotensin-converting enzyme 2 (ACE2)/angiotensin 1–7/MAS axis and the gamma-aminobutyric acid (GABA)ergic signaling system have both been shown to have the dual potential to improve insulin resistance (IR) and hepatic steatosis associated with obesity in the liver. Recent studies have demonstr...
Autores principales: | Chen, Qi, Gao, Yuanyuan, Yang, Fengying, Deng, Hongjun, Wang, Ying, Yuan, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668738/ https://www.ncbi.nlm.nih.gov/pubmed/36265585 http://dx.doi.org/10.1016/j.jbc.2022.102603 |
Ejemplares similares
-
Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016) -
Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021) -
Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection
por: Reese, Lindsey J., et al.
Publicado: (2012) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013) -
Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells
por: Wu, Ying, et al.
Publicado: (2023)